Biotech analysts don’t see HGS takeover on horizon
October 27, 2011 at 14:54 PM EDT
Despite rampant speculation that GlaxoSmithKline may be readying a lucrative bid, biotech analysts say that they don’t see a takeover of Human Genome Sciences on the immediate horizon.
